Specialty Pharmacy

Agents fight cancer by temporarily loosening DNA, increasing the expression of tumor suppressors, and making the tumor more vulnerable.

Powder formulation of HIV drug receives FDA approval.

Filgotinib may offer new option for patients with rheumatoid arthritis who have an inadequate response to methotrexate.

Top news of the day from across the health care landscape.

Use of natural, herbal, vitamin, and traditional cures available in grocery stores, gas stations, drugstores, health food stores, and from the Internet continues to grow.

Symposium on PCSK9 inhibitors in treatment of type 1 diabetes highlighted at 77th Scientific Sessions of the ADA.

Men who have sex with men had the highest number of HIV diagnoses.

The drug is indicated as a combination treatment of HIV and for pre-exposure prophylaxis.

Method could help provide more personalized treatments for patients with skin cancer.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

There are few shortcuts that address the large number of medications and different treatment regimens that are needed to treat patients with HIV.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The National Society of Specialty Pharmacy pushes for the creation of meaningful quality measures to improve direct and indirect remuneration fee reporting.

Both 15-mg and 30-mg doses of upadacitinib achieved desired endpoints in the treatment of rheumatoid arthritis.

Treatment de-escalation would reduce adverse events, treatment costs, and the need for virological monitoring.

Annual relapse rates plummet in patients with multiple sclerosis during extension study.

Sharing cancer data can save lives.

The contaminated fish was sourced from Sustainable Seafood Company and Santa Cruz Seafood.

Top news of the day from across the health care landscape.

Error reporting systems help to promote a culture of open communication in pharmacy.

Time to treatment initiation of cancer treatment increased between 2004 and 2013 from 21 days to 29 days, respectively.

Collaboration between Novartis and IBM Watson Health integrates real-world data and analytical techniques on breast cancer outcomes.

Sandoz is seeking approval of biosimilars adalimumab and infliximab for use in all indications of their respective reference products.

The findings could lead to speed the development of an HIV vaccine.

Top news of the day from across the health care landscape.

Up to 50% of patients with HER2-positive breast cancer treated with targeted therapies develop brain metastases.

FDA approval of valbenazine (Ingrezza) for the iatrogenic movement disorder tardive dyskinesia shows impact of a well-executed development program.